Cargando…

Impact of Antibiotics Use on Cancer-Related and All-Cause Mortality among Patients Receiving Immunotherapy for Advanced Hepatocellular Carcinoma

Detalles Bibliográficos
Autores principales:	Lin, Kong-Ying, Tang, Shi-Chuan, Zhang, Cheng-Wu, Zeng, Yong-Yi, Yang, Tian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801172/ https://www.ncbi.nlm.nih.gov/pubmed/36589729 http://dx.doi.org/10.1159/000525028

Ejemplares similares

Was Concurrent Antibiotic Use during Immunotherapy Associated with Higher Mortality for Patients with Advanced Hepatocellular Carcinoma?
por: Hu, Jia-Yu, et al.
Publicado: (2022)

Advanced precision modeling reveals divergent responses of hepatocellular carcinoma to combinatorial immunotherapy
por: Liu, Jinping, et al.
Publicado: (2023)

Excess All-Cause Mortality During the COVID-19 Outbreak in Japan
por: Yorifuji, Takashi, et al.
Publicado: (2021)

Hyperphosphatemia is not significantly associated with increased all-cause mortality in Korean hemodialysis patients
por: Wakasugi, Minako, et al.
Publicado: (2018)

Multikinase inhibitor-based immunotherapy doublet for advanced hepatocellular carcinoma: its efficacy still needs to be determined
por: Li, Heming, et al.
Publicado: (2023)

COVID-19 deaths in children: comparison with all- and other causes and trends in incidence of mortality
por: Bhopal, S.S., et al.
Publicado: (2020)

Letter to the editor: COVID-19 and all-cause excess mortality in Iran in spring 2020
por: Tadbiri, Hooman, et al.
Publicado: (2020)

Hepatocellular carcinoma and immunotherapy: Beyond immune checkpoint inhibitors
por: Abushukair, Hassan Mohammed, et al.
Publicado: (2022)

Respiratory sarcopenia is a predictor of all‐cause mortality in community‐dwelling older adults—The Otassha Study
por: Kera, Takeshi, et al.
Publicado: (2023)

Relationship between serum uric acid and all-cause mortality in dialysis patients: like being in wonderland, disoriented
por: Zhao, Yu, et al.
Publicado: (2020)

Inequality in the Incidence and Mortality of All Cancers in the World
por: GHONCHEH, Mahshid, et al.
Publicado: (2016)

Comparing Injecting Drug Users with Others Receiving Outpatient Parenteral Antibiotic Therapy
por: Dobson, Pauline M, et al.
Publicado: (2017)

Advances and effectiveness of the immunotherapy after liver transplantation
por: Vulasala, Sai Swarupa R, et al.
Publicado: (2022)

Letter to the Editor: Potent Anticoagulants Are Associated with a Higher All-cause Mortality Rate After Hip and Knee Arthroplasty
por: Eriksson, Bengt I., et al.
Publicado: (2008)

Reply to Letter to Editor: Potent Anticoagulants are Associated with a Higher All-cause Mortality Rate after Hip and Knee Arthroplasty
por: Sharrock, Nigel E., et al.
Publicado: (2008)

The Prognostic Value of TP53 Alteration in Patients with Head and Neck Squamous Cell Carcinoma Receiving Immunotherapy
por: Jiang, Chao, et al.
Publicado: (2022)

Neutrophil to lymphocyte ratio may be predict of mortality in all conditions
por: Balta, S, et al.
Publicado: (2013)

Increased mortality in elderly heart failure patients receiving infusion of furosemide compared to elderly heart failure patients receiving bolus injection
por: Sager, Rana, et al.
Publicado: (2020)

Combined local therapy and CAR‐GPC3 T‐cell therapy in advanced hepatocellular carcinoma: a proof‐of‐concept treatment strategy
por: Shi, Yaoping, et al.
Publicado: (2023)

Children's mortality from COVID-19 compared with all-deaths and other relevant causes of death: epidemiological information for decision-making by parents, teachers, clinicians and policymakers
por: Bhopal, S., et al.
Publicado: (2020)

Future prospect of “Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”
por: Kang, Yong-Bo, et al.
Publicado: (2022)

Let's not blame cocaine as a cause of rhabdomyolysis until all other causes have been ruled out
por: Finsterer, Josef, et al.
Publicado: (2022)

Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Qian, Xinye
Publicado: (2023)

Integrated proteogenomic analysis revealed the metabolic heterogeneity in noncancerous liver tissues of patients with hepatocellular carcinoma
por: Liao, Haotian, et al.
Publicado: (2021)

Neoadjuvant therapy for locally advanced non-small cell lung cancer: TKIs or immunotherapy?
por: Zhang, Zhenyang, et al.
Publicado: (2020)

Smoking signature as a biomarker for immunotherapy
por: Li, Mengqian, et al.
Publicado: (2022)

Is liver transplantation superior to liver resection for hepatocellular carcinoma within Milan criteria?
por: Feng, Qingbo, et al.
Publicado: (2022)

Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.
por: Buetti, Niccolò, et al.
Publicado: (2020)

Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma
por: Rimassa, Lorenza, et al.
Publicado: (2017)

Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Famularo, Simone, et al.
Publicado: (2023)

Predictors of mortality caused by hypothermia in Japan: Author's reply
por: Tokuda, Yasuharu, et al.
Publicado: (2021)

Failure to advance an endotracheal tube over a fiberoptic bronchoscope— “All that glitters is not gold!”
por: Kanaparthi, Astha Agrawal, et al.
Publicado: (2022)

Precise Therapeutic Benefits and Underlying Mechanisms of Anlotinib Combined With Checkpoint Immunotherapy in Advanced Non-Small-Cell Lung Cancer
por: Xiang, Yi, et al.
Publicado: (2022)

Spontaneous rupture of hepatocellular carcinoma trans-arterial embolization or hepatectomy?
por: Feng, Qingbo, et al.
Publicado: (2022)

Hemothorax caused by spontaneous rupture of a metastatic mediastinal lymph node in hepatocellular carcinoma: a case report
por: Oh, Ssang Yong, et al.
Publicado: (2013)

Rule out all differential causes before attributing cerebral bleeding to 5-aminolevulinic acid
por: Finsterer, Josef, et al.
Publicado: (2023)

Before diagnosing postoperative chemical meningitis, all infectious causes must be thoroughly ruled out
por: Finsterer, Josef, et al.
Publicado: (2023)

Reply to Letter to the Editor: Increased Prevalence of Breast and All-cause Cancer in Female Orthopaedic Surgeons
por: Chou, Loretta B., et al.
Publicado: (2023)

Atezolizumab and bevacizumab: the revolutionary duo as a game changer in advanced hepatocellular carcinoma
por: Zhang, D.X.
Publicado: (2020)

Sex differences in COVID-19 mortality: opportunity to develop HSP27 (HSPB1) immunotherapy to treat hyper-inflammation?
por: O’Brien, Edward R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5al5f3l3g5kd8cson7qda5a70m